Delivery Order SPE2DB22D3301-SPE2DB25FY3TM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Propranolol ER 60 mg capsules (100-count bottles) with a ceiling value of $3,180.83. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through an open competition process. The order is set to complete by May 21, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility, which serves as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Propranolol ER 60 mg capsules (100 count) with a ceiling value of $1,571.00. This is a firm fixed-price delivery order with an ultimate completion date of August 7, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor on this order, which will be performed at the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Propranolol ER 120 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,349.13. The award was made on April 25, 2025, with an ultimate completion date of April 28, 2025. This non-competitive, non-set-aside delivery order is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Propranolol ER 60 mg capsules (100 count) on November 3, 2025, with a ceiling value of $6,773.69 and completion deadline of November 4, 2025. This non-set-aside, firm fixed-price delivery order supports the Defense Logistics Agency's medical supply chain operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $2,039.39 to AmerisourceBergen Drug Corp for Propranolol ER 60 mg capsules (100-count units) on November 14, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order represents a non-competitive set-aside procurement and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $2,258.57 firm fixed-price delivery order to AmerisourceBergen Drug Corp on May 15, 2025, for the supply of Propranolol ER 120 mg capsules (100-count units). This is a non-set-aside contract with a completion date of May 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,774.31 to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Propranolol ER 60 mg capsules in quantities of 100 units. This is a firm fixed price delivery order with an ultimate completion date of October 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's capability to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Propranolol ER 120 mg capsules (100-count units) with a ceiling value of $10,415.12. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order, with performance to be completed by August 14, 2025, at the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Propranolol ER 80 mg capsules (100-count units) valued at $12,950.60 under a firm fixed-price contract type. The award was made through a competitive process with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania—the designated place of performance—will fulfill this pharmaceutical delivery order as part of its ongoing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Propranolol ER 120 mg capsules (100-count units) with a ceiling value of $3,785.24. This competitive award, issued May 6, 2025, with completion by May 7, 2025, represents a firm fixed-price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY3TMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 23, 2025, for the supply of Propranolol ER 60 mg capsules (100-count units) with a ceiling value of $2,809.45. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of April 24, 2025. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, was competitively selected to fulfill this medication supply requirement. The company serves military and veteran healthcare systems through its extensive portfolio of pharmaceutical products and medical supplies, demonstrating capability across multiple therapeutic domains. This delivery order represents a routine component of AmerisourceBergen's broader pharmaceutical prime vendor relationship with DLA, which supports the Defense Health Agency and other government healthcare systems with brand-name and generic medications, vaccines, and specialized medical commodities worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 4/23/25 |